Variant report
Variant | nsv823700 |
---|---|
Chromosome Location | chr6:54709648-54710116 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:54556132..54558033-chr6:54708676..54711461,2 | MCF-7 | breast: | |
2 | chr6:54709139..54711220-chr6:54750997..54752618,2 | MCF-7 | breast: | |
3 | chr20:52738859..52741782-chr6:54708785..54710307,2 | MCF-7 | breast: | |
4 | chr6:54709202..54711186-chr6:54779955..54782595,2 | MCF-7 | breast: | |
5 | chr6:54483454..54486448-chr6:54709404..54710933,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
FAM83B | TF binding region |
ENSG00000224984 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4712075 | chr6:54709692-54709693 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs548807228 | chr6:54709721-54709722 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs568711574 | chr6:54709754-54709755 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs78507379 | chr6:54709759-54709760 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs572127750 | chr6:54709791-54709792 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs4715485 | chr6:54709795-54709796 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs12194012 | chr6:54709851-54709852 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs182183760 | chr6:54709867-54709868 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs12207559 | chr6:54709868-54709869 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs541961200 | chr6:54709878-54709879 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs555142997 | chr6:54709883-54709884 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs374812312 | chr6:54709886-54709887 | Weak transcription Enhancers Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs1503133 | chr6:54709911-54709912 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs12216039 | chr6:54709922-54709923 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs552384736 | chr6:54709944-54709945 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564057502 | chr6:54709955-54709956 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532818897 | chr6:54709962-54709963 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532911708 | chr6:54709964-54709965 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12216049 | chr6:54709969-54709970 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs563353350 | chr6:54709986-54709987 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187155056 | chr6:54709990-54709991 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368277027 | chr6:54709992-54709993 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549146198 | chr6:54710008-54710009 | Weak transcription Bivalent/Poised TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12195438 | chr6:54710030-54710031 | Weak transcription Bivalent/Poised TSS Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs145021458 | chr6:54710041-54710042 | Weak transcription Bivalent/Poised TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs151023089 | chr6:54710065-54710066 | Weak transcription Bivalent/Poised TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs17682328 | chr6:54710076-54710077 | Weak transcription Bivalent/Poised TSS Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:54707200-54710800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr6:54707400-54710200 | Weak transcription | NHEK | skin |
3 | chr6:54707400-54710800 | Weak transcription | Placenta | Placenta |
4 | chr6:54709000-54710000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr6:54709000-54710400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr6:54709000-54713400 | Active TSS | Rectal Mucosa Donor 29 | rectum |
7 | chr6:54709000-54714200 | Active TSS | Duodenum Mucosa | Duodenum |
8 | chr6:54709200-54709800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
9 | chr6:54709200-54710200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr6:54709200-54710200 | Enhancers | HMEC | breast |
11 | chr6:54709400-54709800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
12 | chr6:54709400-54710800 | Weak transcription | Fetal Intestine Small | intestine |
13 | chr6:54709600-54709800 | Enhancers | Sigmoid Colon | Sigmoid Colon |
14 | chr6:54709800-54710400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
15 | chr6:54709800-54713400 | Active TSS | Rectal Mucosa Donor 31 | rectum |
16 | chr6:54710000-54710400 | Bivalent/Poised TSS | Primary hematopoietic stem cells | blood |
17 | chr6:54710000-54710600 | Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |